Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 : vimarsana.com

18.04.2024 - NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. Pharming Group N.V. launches new convertible bond ...

Related Keywords

United States , Italy , Netherlands , Frankfurt , Brandenburg , Germany , United Kingdom , France , American Samoa , London , City Of , Amsterdam , Noord Holland , America , Italian , Van Lanschot Kempen , Michael Levitan , Pharming Groupnv , Company Euronext Amsterdam , Exchange Commission , Company The , Linkedin , Frankfurt Stock Exchange , Pharming Group , Bonds , Vp Investor Relations Corporate Communications , Nasdaq , Lifespring Life Sciences Communication , Euronext Amsterdam , New Bonds , Maturity Date , Shareholder Resolution , Cash Alternative Election , Long Stop Date , Fair Bond Value , Physical Settlement Notice , Physical Settlement Date , Open Market , Issue Date , Joint Global Coordinators , Joint Bookrunners , Lanschot Kempen , Eligible Bondholders , Invitation Settlement Date , Expiration Deadline , Securities Act , Joint Dealer Managers , North America , Middle East , Annual Report , Spring Life Sciences Communication ,